UNSPSC 51152048: Tolperisone

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51152048

Definition

This classification denotes a muscle relaxant with the molecular formula C16H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5EOM0LD8E, chemically known as 2,4-dimethyl-3-piperidinopropiophenone but generally known as tolperisone, which bears US NIH Compound Identifier 5511. European Medicines Agency schedules Tolperisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11173MIG.

Read the full definition

The term TOLPERISONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules tolperisone in its Anatomical Therapeutic Chemical (ATC) Classification. TOLPERISONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tolperisone under HS 29333999 and SITC 51574. As of Q4 2014, TOLPERISONE remains the US FDA Preferred Term for this commodity.

Tolperisone bears US NLM identifiers UMLS ID C0040382 and NCI Concept Code C84219. SMILES: O=C(C(CN1CCCCC1)C)C1CCC(CC1)C.

About UNSPSC 51152048

UNSPSC 51152048 Tolperisone is a Commodity code that nominally refers to a specific muscle relaxant pharmaceutical. However, the recent state and local procurement activity tagged under this code does not align with the code's pharmaceutical scope — Seminole County, Florida's solicitation (IFB 60459723LAS, posted June 30, 2026) seeks Naloxone and Safe Drug Deactivation Systems, which are opioid-reversal agents and harm-reduction equipment, not tolperisone. The mismatch suggests either a coding error in the county's tagging system or that state and local procurement offices are using this code as a catch-all for emergency response pharmaceuticals and related equipment. The actual work being solicited is acquisition of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health support, with quarterly deliveries required and all shipping costs included in vendor pricing.

Seminole County is the only recent issuing body identified under this code. The procurement is through a competitive IFB process with a response deadline of July 26, 2023, at 2:00 pm, requiring electronic submission through the county's e-Procurement Portal. The initial contract term is two years with an optional one-year renewal; vendors must carry workers' compensation, commercial general liability, and professional liability insurance, comply with drug-free workplace and E-Verify requirements, and meet potential FEMA compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. A three-month probationary period applies, during which the county may terminate without cause. No explicit small-business set-asides or disadvantaged-enterprise designations are noted. Geographic activity is limited to Florida based on the available record, and no budget ceiling is specified in the sourced materials.

Quick answers

What is UNSPSC 51152048?

UNSPSC 51152048 is Tolperisone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51152048?

UNSPSC 51152048 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51152048

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code